Junctional Naevus

Professional Reference articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

See also separate Black and Brown Skin Lesions article.

These are a form of melanocytic naevus (or mole) where the accumulation of melanocytes is located predominantly at the dermo-epidermal junction, hence their name. Junctional naevi are often quite darkly pigmented and are macular or very thinly papular with only minimal elevation above the level of the skin.[1]They are an acquired lesion and as they age they can change their characteristics to that of a compound naevus, where there are accumulations of melanocytes in the dermis and at the dermo-epidermal junction, which cause the lesion to become increasingly papular.

They occur at any site on the body and are regularly shaped, usually round or oval. They are most often uniform in colour and range in pigmentation from light to dark brown. They are usually <7 mm or so in diameter. They are benign lesions but have the potential to undergo transformation to malignant melanoma.

There are no reliable figures for the prevalence of melanocytic naevi in the general population but they are exceedingly common in congenital and acquired form. They appear in all age groups.[2]Their prevalence is so high that some believe they cannot even be considered an abnormality or pathological entity, as most people with light-coloured skin will have at least a few. They are much more common in ethnic groups with light skin but they still have an appreciable prevalence in those with more pigmented skin. The true frequency of malignant transformation to melanoma is unknown but is known to be higher in lesions greater than 20 cm.[3]

Close-up images of a compound naevus and junctional naevus
Close-up image of a junctional naevus


  • Establish if the lesion is congenital or acquired (junctional naevi are usually acquired).
  • When a lesion presents medically it is important to ascertain whether there have been any associated symptoms such as:
    • Enlargement.
    • Change in shape or size.
    • Change in pigmentation.
    • Itchiness/pain/irritation.
    • Bleeding.


  • Examine the lesion in bright light, preferably daylight if available.
  • Use drawings or photography to note the site(s), size and pigmentation of the lesion(s).
  • Assess for Asymmetry of the lesion, Border (any irregularity?), Colour of lesion, Diameter of the lesion.
  • Establish that the lesion has the typical pattern of pigmentation and is not significantly raised from the level of the skin, to confirm as a junctional naevus.
  • Distinguish from other similar pigmented macules that affect the skin:
    • Freckles (ephelides) are usually multiple, small and darken after sunlight exposure.
    • Café-au-lait spots are usually larger, lighter in pigmentation and have very distinct borders.
    • Lentigines are small, sharply circumscribed and pigmented, surrounded by normal-appearing skin and tend to be multiple, lighter brown and more irregular in shape.
    • Melanoma tends to be darker, have an irregular border, be asymmetrical and have recently grown.
    • Any lesion that has increased in size, become irregular in shape, changed its colour, become heterogeneous in pigmentation, become inflamed, bled, crusted or oozed suggests a possibility of melanoma and should be assessed by excision biopsy.
  • No investigations are necessary in the case of a simple acquired junctional naevus that has not undergone any recent change.
  • Some dermatologists may use dermoscopy to try to distinguish the nature of pigmented lesions.[4]The value of this technique has been demonstrated by several meta-analyses.[5]A new sign - the 'mistletoe sign' - has been described for junctional naevi which are in the inflammatory phase.[6]
  • More recent diagnostic techniques for the identification of melanoma include:[7]
    • In vivo confocal scanning laser microscopy (which uses laser scanning to produce digital images of a patient's skin, with cellular detail similar to that obtained from histology of surgical biopsies).
    • MelaFind® (an automated computer-vision system that captures multi-spectral digital data from pigmented skin lesions).
    • SIAscopy (a non-invasive technique for detecting micro-architectural information, using near infrared and visible spectra light shone from a handset through the skin).
    • Genomic detection.
  • If there is any suspicion of malignant melanoma then the investigation of choice is excision biopsy.[8]
  • Perform excision biopsy or refer if there are ≥2-3 of the following features:
    • Size greater than 7 mm.
    • History of itching.
    • Evidence of inflammation or redness.
    • Increase in diameter.
    • Change in colour, particularly streaming of pigment at edges.
    • Irregular or asymmetrical shape.
    • Previous oozing, crusting or bleeding.
  • If the diagnosis of junctional naevus is clear and there has been no change in a long-standing lesion then reassurance and monitoring of the lesion are all that is usually required.
  • Where there is any doubt as to the diagnosis, perform excision biopsy or refer for dermatological advice. A French study emphasised the importance of training for GPs in the early detection of potentially malignant lesions.[8]
  • Perform excision biopsy whenever the lesion has:
    • Grown.
    • Become symptomatic.
    • Developed asymmetry.
    • Developed an irregular border.
    • Altered its degree or pattern of pigmentation.
    • Developed satellite lesions.

Junctional naevi are, on the whole, benign lesions with a very low risk of transformation to malignant melanoma. Patients with multiple lesions and high sun exposure or episodes of sunburn may be at higher risk of developing melanoma and should be warned of potentially alarming symptoms and reviewed if there is any cause for concern.

Did you find this information useful?

Further reading & references

  1. Sardana K, Chakravarty P, Goel K; Optimal management of common acquired melanocytic nevi (moles): current perspectives. Clin Cosmet Investig Dermatol. 2014 Mar 19 7:89-103. doi: 10.2147/CCID.S57782. eCollection 2014.
  2. Westhafer J, Gildea J, Klepeiss S, et al; Age distribution of biopsied junctional nevi. J Am Acad Dermatol. 2007 May 56(5):825-7.
  3. Hasney C, Butcher RB 2nd, Amedee RG; Malignant melanoma of the head and neck: a brief review of pathophysiology, current staging, and management. Ochsner J. 2008 Winter 8(4):181-5.
  4. Dermoscopic features; DermNet NZ, 2012
  5. Moulin C, Poulalhon N, Duru G, et al; Dermoscopy use by French private practice dermatologists: a nationwide survey. Br J Dermatol. 2013 Jan 168(1):74-9. doi: 10.1111/j.1365-2133.2012.11216.x. Epub 2012 Dec 17.
  6. Kaminska-Winciorek G, Wlaszczuk P, Wydmanski J; "Mistletoe sign": probably a new dermoscopic descriptor for melanoma in situ and melanocytic junctional nevus in the inflammatory stage. Postepy Dermatol Alergol. 2013 Oct 30(5):316-9. doi: 10.5114/pdia.2013.38362. Epub 2013 Oct 30.
  7. Ferris LK, Harris RJ; New diagnostic aids for melanoma. Dermatol Clin. 2012 Jul 30(3):535-45. doi: 10.1016/j.det.2012.04.012.
  8. Grange F, Barbe C, Mas L, et al; The role of general practitioners in diagnosis of cutaneous melanoma: a population-based study in France. Br J Dermatol. 2012 Dec 167(6):1351-9. doi: 10.1111/j.1365-2133.2012.11178.x. Epub 2012 Nov 20.
Original Author:
Dr Sean Kavanagh
Current Version:
Dr Laurence Knott
Peer Reviewer:
Prof Cathy Jackson
Document ID:
4068 (v23)
Last Checked:
27 July 2016
Next Review:
26 July 2021

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. Patient Platform Limited has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.